Bristol-Myers Squibb is a global pharmaceutical company whose mission is to extend and enhance human life through the products we make and the needs we address around the world through our corporate philanthropy, and the Bristol-Myers Squibb Foundation. The Foundation provides no-strings-attached research grants, and supports programs that: - improve the health of women and the health care infrastructure of developing and transitional countries, promote science education, provide disaster relief through products and funding and benefit the communities where our employees live and work. In addition, Bristol-Myers Squibb is a pioneer in the area of patient assistance programs and provides the company’s medicines free of charge to qualified people who are unable to pay for them.

Secure The Future was initially a five-year commitment to address the serious problem of HIV/AIDS in southern and western Africa. Support was provided through community outreach programs and research funding, focusing on vulnerable populations, women and children. It had by mid 2005 awarded nearly 200 grants totalling $120 million in sub-Saharan Africa. The paediatric AIDS corps and children’s clinical centres are the latest additions to the program, through Baylor College of Medicine's Initiative, which has built and operates several of the world's largest paediatric HIV/AIDS treatment centres in developing countries in Africa and Eastern Europe.

"Our goal is to help save the lives of many thousands of African children, many of whom would otherwise face sure death from HIV/AIDS," said Peter R. Dolan, chief executive officer of Bristol-Myers Squibb. "This program brings paediatricians and family practitioners to Africa to treat children and train local health professionals, builds more children's clinical centres from which the physicians will operate, and further reduces the cost of our HIV medicines."